Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1% Market Closed
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Cost of Revenue Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Cost of Revenue
-€34k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Cost of Revenue
-$44.7m
CAGR 3-Years
-61%
CAGR 5-Years
-33%
CAGR 10-Years
-18%
Galapagos NV
AEX:GLPG
Cost of Revenue
-€24.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Cost of Revenue
-€159k
CAGR 3-Years
34%
CAGR 5-Years
46%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Cost of Revenue?
Cost of Revenue
-34k EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Cost of Revenue amounts to -34k EUR.

What is Celyad Oncology SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
23%

Over the last year, the Cost of Revenue growth was 23%.

Back to Top